iifl-logo-icon 1

Fischer Medical Ventures Ltd Share Price

648.8
(4.99%)
Jul 18, 2024|03:40:00 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open625
  • Day's High648.8
  • 52 Wk High792.65
  • Prev. Close617.95
  • Day's Low595
  • 52 Wk Low66.8
  • Turnover (lac)8.21
  • P/E0
  • Face Value10
  • Book Value14.73
  • EPS0.08
  • Mkt. Cap (Cr.)3,471.08
  • Div. Yield0
No Records Found

Fischer Medical Ventures Ltd KEY RATIOS

Sector

Trading

Open

625

Prev. Close

617.95

Turnover(Lac.)

8.21

Day's High

648.8

Day's Low

595

52 Week's High

792.65

52 Week's Low

66.8

Book Value

14.73

Face Value

10

Mkt Cap (₹ Cr.)

3,471.08

P/E

0

EPS

0.08

Divi. Yield

0

Fischer Medical Ventures Ltd Corporate Action

21 May 2024

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

28 Aug 2023

12:00 AM

AGM

Announcement Date: 28 Aug, 2023

arrow

18 Dec 2023

12:00 AM

BookCloser

arrow

15 Dec 2023

12:00 AM

EGM

arrow

Fischer Medical Ventures Ltd NEWS AND UPDATE

No data found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Fischer Medical Ventures Ltd SHAREHOLDING SNAPSHOT

18 Jul, 2024|11:02 PM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 62.01%

Foreign: 62.01%

Indian: 12.89%

Non-Promoter- 6.75%

Institutions: 6.75%

Non-Institutions: 18.33%

Custodian: 0.00%

Share Price

Fischer Medical Ventures Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Loading...
Y/e 31 Mar( In .Cr)Mar-2023Mar-2022Mar-2021Mar-2020

Equity Capital

0.17

0.17

0.17

0.17

Preference Capital

0

0

0

0

Reserves

-0.44

-0.4

-0.17

-0.31

Net Worth

-0.27

-0.23

0

-0.14

Minority Interest

View Balance Sheet
Loading...
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Revenue

0.16

0

0

0

yoy growth (%)

0

0

0

0

Raw materials

0

0

0

0

As % of sales

0

0

0

0

Employee costs

-0.07

-0.08

-0.01

-0.01

View Profit & Loss
Loading...
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Profit before tax

-0.03

-0.04

0

-0.06

Depreciation

0

0

0

0

Tax paid

0.17

0

0

0

Working capital

-0.02

-0.05

0.1

0.03

Other operating items

View Cash Flow
Loading...

No Record found

View Ratios
Particulars (Rupees in Crores.)Mar-2024

Gross Sales

20.98

Excise Duty

0

Net Sales

20.98

Other Operating Income

0

Other Income

0.5

Fischer Medical Ventures Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Adani Enterprises Ltd

ADANIENT

3,110

126.943,54,540.35776.710.049,210.18145.96

Aegis Logistics Ltd

AEGISLOG

897

77.631,484.7125.880.36721.5167.87

Cello World Ltd

CELLO

990.15

352.3721,870.9318.620.15260.7765.65

Redington Ltd

REDINGTON

207.9

15.6216,253.09160.572.9810,490.2446.35

Honasa Consumer Ltd

HONASA

484.75

129.9615,717.7426.710427.1734.67

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Fischer Medical Ventures Ltd

Management

Register Office

Registrar Office

Non Executive Director

Sejal Soni

Independent Non Exe. Director

Ashishkumar Dhakan

Independent Director

Krishna Kumar Omprakash Dubey

Independent Women Director

Jeena Dineshchandra Suthar

Director & CFO

Dilip Suryakant Jha

Company Sec. & Compli. Officer

Deepak Vyas

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

Fischer Chemic Ltd. was incorporated as a Public Limited Company and obtained Certificate of Commencement of Business. The Company formed an agreement with the Partnership firm M/s. Fischer Inorganics & Aromatics, Chennai to take over the partnership business as a going concern dated 19th January 1994. The partnership firm was engaged in the processing/Manufacturing of Laboratory Grade Chemicals. The Company had already engaged in the manufacturing of certain grades of Laboratory Chemicals in its plant situated at Aminijikarai and Palavakkam, near Chennai City (taken over from the partnership firm M/s Fischer Inorganics and Aromatics). These Grades of Laboratory Chemicals are broadly clasified as SALTS. Thereafter, it changed the product mix tailored to specific endusers and bulk customers.
Read More

Company FAQs

What is the Fischer Medical Ventures Ltd share price today?

Down Arrow

The Fischer Medical Ventures Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is Rs.₹648.8 today.

What is the Market Cap of Fischer Medical Ventures Ltd?

Down Arrow

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Fischer Medical Ventures Ltd is ₹3471.08 Cr. as of 18 Jul ‘24

What is the PE and PB ratio of Fischer Medical Ventures Ltd?

Down Arrow

The PE and PB ratios of Fischer Medical Ventures Ltd is 0 and 41.95 as of 18 Jul ‘24

What is the 52 Week High and Low of Fischer Medical Ventures Ltd?

Down Arrow

The 52-week high/low is the highest and lowest price at which a Fischer Medical Ventures Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Fischer Medical Ventures Ltd is ₹66.8 and ₹792.65 as of 18 Jul ‘24

What is the CAGR of Fischer Medical Ventures Ltd?

Down Arrow

Fischer Medical Ventures Ltd's CAGR for 5 Years at 51.77%, 3 Years at 154.59%, 1 Year at 431.80%, 6 Month at 139.52%, 3 Month at 1.27% and 1 Month at -11.60%.

What is the shareholding pattern of Fischer Medical Ventures Ltd?

Down Arrow

The shareholding pattern of Fischer Medical Ventures Ltd is as follows:
Promoters - 74.91 %
Institutions - 6.76 %
Public - 18.33 %

Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.